Safety and efficacy of fenebrutinib in relapsing multiple sclerosis (FENopta): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial and open-label extension study

Journal:
The Lancet Neurology
Published:
DOI:
10.1016/s1474-4422(25)00174-7
Affiliations:
31
Authors:
33
Go to article
Institutions Authors Share
Genentech, Inc., United States of America (USA)
11.000000
11.000000
 0.33
Lou Ruvo Center for Brain Health, Cleveland Clinic, United States of America (USA)
2.000000
 0.06
Charles University (CU), Czech Republic
1.000000
 0.03
University Hospital Bratislava, Slovakia
1.000000
 0.03
Sharlin Health and Neurology, United States of America (USA)
1.000000
 0.03
Military Medical Academy (MMA), Serbia
1.000000
 0.03
University of Pennsylvania (Penn), United States of America (USA)
1.000000
 0.03
University Clinical Centre of the Republic of Srpska, Bosnia and Herzegovina
1.000000
 0.03
University of Niš, Serbia
1.000000
 0.03
Clinical Hospital Center Zemun, Serbia
1.000000
 0.03
University Clinical Centre of Serbia, Serbia
1.000000
 0.03
General Hospital Varaždin, Croatia
1.000000
 0.03
University Hospital Centre Zagreb (KBC Zagreb), Croatia
1.000000
 0.03
Nemocnice Jihlava, Czech Republic
1.000000
 0.03
Fullerton Neurology and Headache Center, United States of America (USA)
1.000000
 0.03
University of Rijeka (UNIRI), Croatia
1.000000
 0.03
University of Kragujevac, Serbia
1.000000
 0.03
University Hospital Hradec Králové, Czech Republic
0.500000
 0.02
University Medical Center Göttingen (UMG), Germany
0.500000
 0.02
Solmed Clinic, Croatia
0.500000
 0.02
University Hospital Sveti Duh, Croatia
0.500000
 0.02
Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Germany
0.500000
 0.02
St. Anne's University Hospital Brno (FNUSA), Czech Republic
0.500000
 0.02
Masaryk University (MU), Czech Republic
0.500000
 0.02
St. Michael's Hospital, Canada
0.500000
 0.02
University of Toronto (U of T), Canada
0.500000
 0.02
General University Hospital in Prague, Czech Republic
0.500000
 0.02
Interested in Pharmacology and Pharmaceutical Sciences?